LivaNova PLC
NASDAQ:LIVNMedical - Devices
+$0.76 today
- Market cap
- $5.21B
- Beta
- 0.88
- P/E (TTM)
- 40.5
- EPS (TTM)
- $1.96
Volume 1.32M
Average 0.79M
LIVN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
LivaNova PLCNASDAQ: LIVN
Total Equity · Q3 FY2026 · quarter ended Sep 2026
Total equity rises 18.6% from a year ago
Total equity stood at $1.37B at the end of Q3 FY2026, up 18.6% from a year earlier and up 3.5% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.
Context
- Total equity amounted to 50.6% of total assets at the end of Q3 FY2026, up 5.3 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +18.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 1.2B USD
- Year-over-year change
- -9.1%
- 4-year CAGR
- -1.9%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.2B | -9.1% |
| FY2024 | 2024-12-31 | 1.32B | +3.3% |
| FY2023 | 2023-12-31 | 1.28B | +5.8% |
| FY2022 | 2022-12-31 | 1.21B | -6.7% |
| FY2021 | 2021-12-31 | 1.29B | — |
Total Equity vs competitors
How LIVN compares with its peers on the latest reported figures
- LIVN's Sep 2026 total equity of $1.37B is the 5th highest of the 10 companies compared; the peer median is $837.1M.
- Its year-over-year change of +18.6% is the 2nd highest of 10, against a peer median of +1.1%.
- Total equity amounts to 50.6% of total assets for LIVN, versus a peer median of 54.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $50.85B | +5.6% | -1.0% | 54.5% | |
| Jun 2026 | $25.17B | +11.1% | +11.7% | 55.7% | |
| Jun 2026 | $10.72B | +1.1% | +21.2% | 77.3% | |
| Jun 2026 | $6.59B | +10.3% | +16.8% | 73.4% | |
| Sep 2026 | $1.37B | +18.6% | -0.2% | 50.6% | |
| Jun 2026 | $837.1M | -5.1% | -0.9% | 35.4% | |
| Jun 2026 | $825.58M | +21.8% | +16.3% | 89.2% | |
| Mar 2026 | $29.11M | -58.0% | -28.9% | 29.2% | |
| Mar 2026 | $17.06M | -56.8% | -22.8% | 13.6% | |
| Mar 2026 | $14.45M | -40.4% | -18.2% | 14.6% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding LIVN) | $837.1M | +1.1% | -0.9% | 54.5% | |
Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 207.99M | 214.17M | 266.5M | 428.86M | 635.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 222.98M | 214.82M | 215.07M | 223.7M | 216M |
| Inventory | 105.84M | 129.38M | 147.89M | 147.57M | 164.7M |
| Other Current Assets | 104.75M | 296.06M | 311.37M | 327.06M | 85.3M |
| Total Current Assets | 679.18M | 886.14M | 988.16M | 1.13B | 1.1B |
| Property, Plant & Equipment (Net) | 190.67M | 183.02M | 205.03M | 217.1M | 298.1M |
| Goodwill | 899.53M | 768.79M | 782.94M | 750.01M | 792.8M |
| Intangible Assets | 399.68M | 368.56M | 261.18M | 237.29M | 230M |
| Long-term Investments | 16.6M | 16.27M | 22.84M | 25.08M | 20.3M |
| Tax Assets | 2.2M | 1.38M | 118.86M | 111.86M | 111M |
| Other Non-current Assets | 13.1M | 70.62M | 50.56M | 37.87M | 52.3M |
| Total Non-current Assets | 1.52B | 1.41B | 1.44B | 1.38B | 1.5B |
| Total Assets | 2.2B | 2.29B | 2.43B | 2.51B | 2.61B |
| Account Payables | 68M | 74.31M | 80.85M | 69.73M | 97.2M |
| Short-term Debt | 229.67M | 23.43M | 18.11M | 78M | 31.5M |
| Tax Payables | 15.14M | 16.51M | 23.34M | 32.46M | 33.1M |
| Deferred Revenue | 8.42M | 10.23M | 10.73M | 10.85M | 0 |
| Other Current Liabilities | 297.76M | 109.23M | 98.97M | 51.2M | 553.4M |
| Total Current Liabilities | 696.97M | 297.4M | 334.98M | 392.13M | 808.1M |
| Long-term Debt | 9.85M | 518.07M | 568.54M | 549.62M | 393.5M |
| Deferred Tax Liabilities | 7.73M | 8.52M | 11.57M | 10.92M | 9.6M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 155.84M | 233.62M | 191.45M | 193.36M | 146.6M |
| Total Non-current Liabilities | 209.34M | 789.75M | 816.95M | 794.01M | 598M |
| Total Liabilities | 906.31M | 1.09B | 1.15B | 1.19B | 1.41B |
| Common Stock | 82.3M | 82.42M | 82.53M | 83.16M | 0 |
| Retained Earnings | (897.78M) | (984.03M) | (966.48M) | (903.25M) | 0 |
| Accumulated OCI | (7.18M) | (48.12M) | (27.88M) | (80.17M) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 1.2B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.29B | 1.21B | 1.28B | 1.32B | 1.2B |
| Total Debt | 286.7M | 580.43M | 640.4M | 676.77M | 473.3M |
| Net Debt | 78.71M | 366.26M | 373.9M | 247.92M | (162.3M) |
LivaNova PLC
NASDAQ:LIVN
Intrinsic Alpha fair value
Locked
Current Price
$94.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.